Fen Zhou

1.0k citations
36 papers · 727 indexed · h-index 13
Topics
Acute Myeloid Leukemia Research (7 papers)Acute Lymphoblastic Leukemia research (7 papers)Childhood Cancer Survivors' Quality of Life (5 papers)
Journals
SHILAP Revista de lepidopterologíaBloodBiochemical Journal
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Fen Zhou

34 papers receiving 700 citations

Peers

Fen Zhou
Comparison fields: 5 of 102
  • Molecular Biology 172
  • Oncology 120
  • Biochemistry 105
  • Pediatrics, Perinatology and Child Health 104
  • Physiology 101
Replace Remise Gelışgen with:
Remise Gelışgen Türkiye
Uğur Atik Türkiye
Anna Perri Italy
Hoda A. El‐Bahrawy Egypt
Paula Maldonado Brazil
Ralf M. W. Moison Netherlands
Soudabeh Fallah Iran
Irit Maor Israel
Mitsuhiro Goda Japan
Ponvijay Kombairaju United States
Fen Zhou relative to Remise Gelışgen Türkiye Remise Gelışgen's profile →
Citations per field
00.5×1.5×1.9×
Remise Gelışgen · 1×
Citations per year

Countries citing papers authored by Fen Zhou

Since Specialization
Citations

This map shows the geographic impact of Fen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Zhou more than expected).

Fields of papers citing papers by Fen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Zhou. The network helps show where Fen Zhou may publish in the future.

Co-authorship network of co-authors of Fen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Fen Zhou. A scholar is included among the top collaborators of Fen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fen Zhou. Fen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 10
5 25
6 2
7 3
8 6
9 37
10 2
11 2
12 9
13 7
14 6
15 6
16 99
17 48
18 13
19 67
20 13

About Fen Zhou

Fen Zhou is a scholar working on Hematology, Biochemistry and Applied Microbiology and Biotechnology, having authored 36 papers that have together received 727 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Biochemistry (105 citations), Hematology (68 citations) and Biochemistry (42 citations). Fen Zhou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Dale A. Parks, C. Roger White, Rakesh P. Patel, Vance G. Nielsen, Runming Jin, Sidhartha Tan, Candece L. Gladson, Victor Darley‐Usmar, Nicholas K.H. Khoo and Takafumi Inoue. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026